Pneumococcal vaccination in celiac disease

Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):541-546. doi: 10.1080/17474124.2019.1607295. Epub 2019 Apr 23.

Abstract

Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure in genetically predisposed subjects. Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients. Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition in both the general population and celiac patients. Pneumococcal vaccination is the most effective means for its prevention. Expert opinion: In CD, evaluation of spleen function should be useful to select patients who may benefit from vaccination to reduce the risk of pneumococcal disease. Different strategies could be employed: physicians could search for signs of hyposplenism on peripheral blood smear or abdominal ultrasound. However, the best strategy to identify which patients will benefit from pneumococcal vaccination has not yet been defined.

Keywords: Celiac disease; hyposplenism; infections; pneumococcal vaccination; pneumonia.

Publication types

  • Review

MeSH terms

  • Animals
  • Celiac Disease / diagnosis
  • Celiac Disease / genetics
  • Celiac Disease / immunology*
  • Humans
  • Hypersplenism / diagnosis
  • Hypersplenism / immunology
  • Immunocompromised Host*
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / immunology
  • Opportunistic Infections / microbiology
  • Opportunistic Infections / prevention & control*
  • Pneumococcal Infections / diagnosis
  • Pneumococcal Infections / immunology
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines / administration & dosage*
  • Pneumococcal Vaccines / adverse effects
  • Prognosis
  • Protective Factors
  • Risk Factors
  • Spleen / immunology
  • Spleen / pathology
  • Vaccination*

Substances

  • Pneumococcal Vaccines